"[T]he prices that US providers negotiate with insurers are aberrantly high and that the level of providers' commercial prices differentially raises health spending in the US compared to other nations. However, it is crucial to note that the regulated prices US providers are paid by the Medicare and Medicaid program are not hugely out of sync with the regulated prices set in other countries."  MORE >>